Uldry P A, Bogousslavsky J, Regli F
Department of Neurology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Schweiz Arch Neurol Psychiatr (1985). 1991;142(4):301-5.
We treated a 93-year-old woman with Guillain-Barré syndrome (GBS) with high-dose intravenous immunoglobulin (IgIV). The patient improved within 48 hours of the onset of treatment. There were no adverse side effects.
我们用大剂量静脉注射免疫球蛋白(IgIV)治疗了一名93岁的格林-巴利综合征(GBS)女性患者。患者在治疗开始后的48小时内病情有所改善。没有出现不良副作用。